- Home
- NVCR vs NMZ Comparison
NVCR vs NMZ Comparison
Compare NVCR & NMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- NMZ
- Stock Information
- Founded
- NVCR 2000
- NMZ 2003
- Country
- NVCR Switzerland
- NMZ United States
- Employees
- NVCR N/A
- NMZ N/A
- Industry
- NVCR Medical/Dental Instruments
- NMZ Finance/Investors Services
- Sector
- NVCR Health Care
- NMZ Finance
- Exchange
- NVCR Nasdaq
- NMZ Nasdaq
- Market Cap
- NVCR 1.4B
- NMZ 1.1B
- IPO Year
- NVCR 2015
- NMZ N/A
- Fundamental
- Price
- NVCR $11.32
- NMZ $10.07
- Analyst Decision
- NVCR Buy
- NMZ
- Analyst Count
- NVCR 7
- NMZ 0
- Target Price
- NVCR $28.79
- NMZ N/A
- AVG Volume (30 Days)
- NVCR 1.7M
- NMZ 356.8K
- Earning Date
- NVCR 07-24-2025
- NMZ 01-01-0001
- Dividend Yield
- NVCR N/A
- NMZ 5.08%
- EPS Growth
- NVCR N/A
- NMZ N/A
- EPS
- NVCR N/A
- NMZ N/A
- Revenue
- NVCR $630,160,000.00
- NMZ N/A
- Revenue This Year
- NVCR $6.15
- NMZ N/A
- Revenue Next Year
- NVCR $7.35
- NMZ N/A
- P/E Ratio
- NVCR N/A
- NMZ N/A
- Revenue Growth
- NVCR 14.58
- NMZ N/A
- 52 Week Low
- NVCR $10.91
- NMZ $8.26
- 52 Week High
- NVCR $34.13
- NMZ $11.14
- Technical
- Relative Strength Index (RSI)
- NVCR 25.05
- NMZ 48.08
- Support Level
- NVCR $10.91
- NMZ $9.83
- Resistance Level
- NVCR $12.38
- NMZ $9.94
- Average True Range (ATR)
- NVCR 0.93
- NMZ 0.08
- MACD
- NVCR -0.49
- NMZ 0.00
- Stochastic Oscillator
- NVCR 6.13
- NMZ 52.17
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About NMZ Nuveen Municipal High Income Opportunity Fund $0.01 par value per share
Nuveen Municipal High Income Opp Fund is a diversified, closed-end management investment company. The company's investment objectives is to provide current income exempt from regular federal income tax by investing predominantly in a portfolio of municipal obligations issued by state and local government authorities or certain U.S. territories. It seeks to provide attractive monthly tax-free income, portfolio diversification and attractive after tax total returns. The fund invests in municipal securities that are exempt from federal income taxes.